
    
      The primary objective of this study is to investigate the effect of AERODERM (also known as
      pitrakinra, AER 001, BAY 16-9996) on Eczema Area and Severity Index (EASI) score in subjects
      with moderate to severe atopic eczema in a randomised, placebo controlled, parallel-group
      study with bid sc. dosing of AERODERM for 28 days
    
  